Your browser doesn't support javascript.
loading
The hepatitis C care cascade among people who inject drugs accessing harm reduction services in Catalonia: Major gaps for migrants.
Folch, Cinta; Saludes, Verónica; Reyes-Ureña, Juliana; Antuori, Adrián; Ibáñez, Nuria; Majó, Xavier; Colom, Joan; Matas, Lurdes; Casabona, Jordi; Martró, Elisa.
Afiliação
  • Folch C; Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain; Group 27, Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, S
  • Saludes V; Group 27, Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias Pujol, Institut d'Investigació Germans Trias i Pujol (IGTP),
  • Reyes-Ureña J; Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain; Group 27, Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, S
  • Antuori A; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias Pujol, Institut d'Investigació Germans Trias i Pujol (IGTP), Badalona, Spain; Genetics and Microbiology Department, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Ibáñez N; Programme for Prevention, Control and Treatment of HIV, STIs and Viral Hepatitis. ASPCAT, Badalona, Spain.
  • Majó X; Programme for Prevention, Control and Treatment of HIV, STIs and Viral Hepatitis. ASPCAT, Badalona, Spain.
  • Colom J; Programme for Prevention, Control and Treatment of HIV, STIs and Viral Hepatitis. ASPCAT, Badalona, Spain.
  • Matas L; Group 27, Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias Pujol, Institut d'Investigació Germans Trias i Pujol (IGTP),
  • Casabona J; Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain; Group 27, Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, S
  • Martró E; Group 27, Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias Pujol, Institut d'Investigació Germans Trias i Pujol (IGTP),
Int J Drug Policy ; 90: 103057, 2021 04.
Article em En | MEDLINE | ID: mdl-33310634
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Migrantes / Preparações Farmacêuticas / Abuso de Substâncias por Via Intravenosa / Hepatite C Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Migrantes / Preparações Farmacêuticas / Abuso de Substâncias por Via Intravenosa / Hepatite C Idioma: En Ano de publicação: 2021 Tipo de documento: Article